Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2023 Q3
10 of 19 quarters
Total Value
$115.36M
Total Shares
5.63M
Net Share Change
+1.25M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$115.36M
5.63M
2.6%
ADD
+1.25M
(+28.5%)
Maverick Capital
$115.36M
5.63M shares
ADD
+1.25M
(+28.5%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy